Correlation Between Ono Pharmaceutical and Summit Midstream

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ono Pharmaceutical and Summit Midstream at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ono Pharmaceutical and Summit Midstream into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ono Pharmaceutical Co and Summit Midstream Partners, you can compare the effects of market volatilities on Ono Pharmaceutical and Summit Midstream and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ono Pharmaceutical with a short position of Summit Midstream. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ono Pharmaceutical and Summit Midstream.

Diversification Opportunities for Ono Pharmaceutical and Summit Midstream

-0.65
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Ono and Summit is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Ono Pharmaceutical Co and Summit Midstream Partners in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Summit Midstream Partners and Ono Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ono Pharmaceutical Co are associated (or correlated) with Summit Midstream. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Summit Midstream Partners has no effect on the direction of Ono Pharmaceutical i.e., Ono Pharmaceutical and Summit Midstream go up and down completely randomly.

Pair Corralation between Ono Pharmaceutical and Summit Midstream

If you would invest  1,326  in Ono Pharmaceutical Co on September 13, 2024 and sell it today you would lose (76.00) from holding Ono Pharmaceutical Co or give up 5.73% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy0.0%
ValuesDaily Returns

Ono Pharmaceutical Co  vs.  Summit Midstream Partners

 Performance 
       Timeline  
Ono Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ono Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable essential indicators, Ono Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Summit Midstream Partners 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Summit Midstream Partners has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable essential indicators, Summit Midstream is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Ono Pharmaceutical and Summit Midstream Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ono Pharmaceutical and Summit Midstream

The main advantage of trading using opposite Ono Pharmaceutical and Summit Midstream positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ono Pharmaceutical position performs unexpectedly, Summit Midstream can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Summit Midstream will offset losses from the drop in Summit Midstream's long position.
The idea behind Ono Pharmaceutical Co and Summit Midstream Partners pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA